Follicular Lymphoma: The "Watch and Wait" Strategy Explained
Watch and Wait (W&W)—active surveillance without immediate therapy—is standard for asymptomatic advanced-stage follicular lymphoma (FL). It spares toxicity without compromising survival.
Why W&W Is Appropriate
- Indolent Natural History: Median survival >15–20 years; many never need treatment.
- No Survival Benefit to Early Treatment: Multiple RCTs (e.g., Ardeshna, UK LG1) show equivalent OS for early vs. delayed treatment.
- Treatment Toxicity: Chemoimmunotherapy causes cytopenias, neuropathy, secondary malignancies, infertility, fatigue — deferred until necessary.
- Preserves Future Options: Avoids resistance; maintains fitness for novel agents.
W&W Protocol
- Visits every 3–6 months: history, exam, CBC, LDH, β2-microglobulin.
- Imaging: CT every 6–12 months (or PET if transformation suspected); less frequent if stable.
- Patient education: Report new nodes, B-symptoms, early satiety, bleeding.
Triggers to Initiate Therapy
- GELF criteria (see Article 154945)
- POD24 (progression <24 mo after 1L) — high-risk biology
- Transformation suspicion (rapid growth, LDH↑, new B-symptoms) → biopsy
- Patient anxiety/preference (valid after informed discussion)
Psychological Support
- Reframe: "Active monitoring" not "doing nothing."
- Mindfulness, CBT, peer support (Lymphoma Coalition, FL groups).
- Clinician validates concern at each visit.
Outcome
~20–30% never require treatment. For those who do, outcomes identical to early-treated. W&W is evidence-based, not neglect.
Lymphoma - Related Articles
- Lymphangiogram (Lymphangiography): Procedure, Techniques, and Indications
- Causes of Death in Non-Lymphoma Cancers: Organ Failure and Systemic Effects
- Stem Cell & Bone Marrow Transplant Risks: What You Need to Know
- Mediastinal Lymphadenopathy: Term Breakdown and Clinical Meaning
- Understanding Chemotherapy for Lymphoma: Treatment Options & Regimens
- Mantle Cell Lymphoma and Vietnam Service: No Established Link to Agent Orange
- Limited vs. Total Lymphadenectomy: Key Differences, Benefits, and Risks
